Genix Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jul '25 Jul 3, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	2015 - 2019
Market Capitalization	2	3	2	4	9	10	Upgrade
Market Cap Growth	-40.00%	25.00%	-38.46%	-56.67%	-9.37%	273.29%	Upgrade
Enterprise Value	3	4	3	4	9	9	Upgrade
Last Close Price	0.04	0.05	0.04	0.07	0.15	0.17	Upgrade
PS Ratio	1942.69	730.98	191.87	-	-	-	Upgrade
PB Ratio	-1.54	-2.50	-2.08	1.20	2.21	2.02	Upgrade
P/TBV Ratio	-	-	-	-	-	43.40	Upgrade
EV/Sales Ratio	-	910.96	225.59	-	-	-	Upgrade
EV/EBITDA Ratio	15.25	20.25	-	-	-	-	Upgrade
Debt / Equity Ratio	-0.72	-0.69	-0.45	0.06	0.01	0.00	Upgrade
Debt / EBITDA Ratio	4.85	4.48	-	-	-	-	Upgrade
Asset Turnover	0.01	0.03	0.01	-	-	-	Upgrade
Inventory Turnover	-	-	0.06	-	-	-	Upgrade
Quick Ratio	0.01	0.01	0.01	0.02	0.19	2.01	Upgrade
Current Ratio	0.03	0.03	0.16	0.23	0.25	2.05	Upgrade
Return on Equity (ROE)	-	-	-426.41%	-29.78%	-37.25%	-29.85%	Upgrade
Return on Assets (ROA)	-150.19%	-169.16%	-23.23%	-13.83%	-19.90%	-15.75%	Upgrade
Return on Capital (ROIC)	-	-	-37.73%	-16.76%	-22.53%	-17.49%	Upgrade
Earnings Yield	-4.22%	-2.47%	-185.55%	-27.90%	-18.60%	-7.33%	Upgrade
FCF Yield	-	-6.33%	-9.31%	-5.70%	-4.82%	-1.99%	Upgrade
Buyback Yield / Dilution	-	-	-	-	-18.55%	-33.17%	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.